Abstract
Introduction: A prediction tool that was developed by Villar et al. in Spain called ‘APPS’ tool was shown to accurately predict in-hospital mortality in moderate and severe Acute Respiratory Syndrome (ARDS) patients on lung-protective ventilation. A simple 9-point score that utilized the variables of age, PaO2/FiO2 ratio and Plateau pressure measured at 24 hours after diagnosis of ARDS divided patients into groups of low, moderate and high mortality risk. We have attempted to validate APPS tool to correlate mortality in a cohort of ARDS patients at a tertiary care hospital in the US.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
